Simultaneous expansion of tumor-infiltrating neutrophils in the same treatment groups suggest a previously unknown mechanism by which TREM1 deficiency drives neutrophil-dependent expansion of UTCαβ antitumorigenic immunity and warrants further research. The gene discussed is TREM1; the disease is neoplasm.